Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
about
Model structure of human APOBEC3GDeaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminaseSole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificitiesDifferential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityAPOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replicationHuman APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GIntracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allThe APOBEC3 family of retroelement restriction factorsHIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partnerRoles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactionsNewly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase HCharacterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsA DNA sequence recognition loop on APOBEC3A controls substrate specificityAPOBEC3G: an intracellular centurionAID and Apobec3G haphazard deamination and mutational diversityReduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteinsFunctions and regulation of the APOBEC family of proteinsLeveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.Random mutagenesis MAPPIT analysis identifies binding sites for Vif and Gag in both cytidine deaminase domains of Apobec3G.Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3GAntiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granulesMonomeric APOBEC3G is catalytically active and has antiviral activity.Function of a retrotransposon nucleocapsid proteinFeatures, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.APOBEC deaminases-mutases with defensive roles for immunity.
P2860
Q21092257-DD409D40-E951-4CB5-8EC3-51858C89B3D8Q21131577-28673530-8A63-4C13-B96A-99FE08BB470EQ24317568-99CC5491-044A-4ED0-8FB7-7B2AB3035601Q24521469-30DB402D-2630-4F3C-B671-675A35691075Q24529150-92A9C22A-CC8B-4FE7-AAFE-55C734016120Q24537623-F6842AEC-D055-4B60-8E70-3B3885B31DB5Q24619114-F0373796-95A7-49AB-B15B-7DCC2ABAF3B9Q24647833-5E9AC4A8-9784-447C-9BC2-DA4A72B3C816Q24651400-7FD74D74-392D-42F5-9C99-ECF1776D9F35Q24655541-7AF91912-8CD3-4A3D-B020-A8463AB5D165Q24670173-9B13DD45-E228-49BE-8BDE-5C77CDA978E6Q24672209-3CF81C5B-2C17-4EDE-8C97-954040D9850CQ24681427-6261FDBB-B1C4-4D60-98F2-F756158B39F0Q24805644-67883D15-0273-4ADA-8AB2-E4A43FAF7020Q26823568-49B5EB33-82F2-4221-A7E2-9C823CEEE7CFQ26862780-E1CCD32A-948F-49FD-B925-01EE3ACAFF47Q27302871-F9FCCEC9-D40F-4171-8BC5-53162134B48FQ28286819-0C7B8019-EB0B-4B97-9510-668C8AE02690Q28469134-54409C2F-B3A7-4480-AA1D-A85DCA1AACA8Q28482052-026338C1-AE95-4BDA-9FC6-247B9540EE89Q28538801-A7E80C99-5699-4B6C-BCF0-BF1464F27CEEQ28754989-1D4B16D8-9582-47B0-8F75-AD833F725E90Q30537745-45E35777-6347-415C-8216-F4CD090B52F3Q31078477-118A5F1D-236F-4981-A28B-29822EA95E60Q33328499-9C777C72-0588-464F-88E5-35C65DD45FD4Q33393637-FCF888FB-2DF7-40AC-93DE-B69A87C0972AQ33595661-296684BD-20BB-4E84-9E2D-329FACF172C7Q33654949-B426F081-BB9E-46AE-9E95-45337A16321AQ33755180-2409E951-F1AA-49C9-A161-A9D91EA47A70Q33852042-0F165DC9-3777-460E-AF82-143B75488CE8Q33892198-988D2770-8848-4AF7-AA4D-FB965C082E96Q34412223-F1BE2A95-1C89-493D-8AD9-C6BB3D4A7008Q34416419-29B39024-3953-4F80-87D9-E5B08AAFA6DDQ34536866-F36C8A56-64F9-4B30-9504-A278F9D521D7Q34590679-CF66266F-B861-45F7-B2C6-F94E67BFF457Q34647942-4ECBFC5B-CFBC-4605-A81F-70BDE1DA0C3CQ34775636-CB6C9020-7D8B-42C4-911E-02623FD3045AQ34775654-61E58677-8B74-41FF-8B4F-6F0E870D0D0EQ34972927-D243E68E-50F4-4F33-9925-AE46EDC28B9AQ35012747-C8686924-1185-4714-B9A5-623AD830F6AD
P2860
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@en
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@nl
type
label
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@en
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@nl
prefLabel
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@en
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@nl
P2093
P2860
P1433
P1476
Amino-terminal region of the h ...... for human APOBEC3G packaging.
@en
P2093
Bindong Liu
Xianghui Yu
Xiao-Fang Yu
Zuoxiang Xiao
P2860
P304
11841-11852
P356
10.1128/JVI.78.21.11841-11852.2004
P407
P577
2004-11-01T00:00:00Z